Department of Medical Imaging, University Health Network and Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario M5G 1X5, Canada.
J Vasc Interv Radiol. 2010 Apr;21(4):496-502. doi: 10.1016/j.jvir.2009.12.395. Epub 2010 Mar 1.
To determine the clinical effectiveness of stent-graft placement in dysfunctional autogenous hemodialysis fistulas.
Between September 2006 and June 2008, 24 Fluency Plus stent-grafts were inserted in 17 patients with failing autogenous hemodialysis fistulas (two radiocephalic, 12 brachiocephalic, and three brachiobasilic). Six fistulas were thrombosed at presentation. Indications for stent-graft insertion included 10 residual stenoses, six pseudoaneurysms, and one fistuloplasty-induced rupture. Fistula function before and after intervention was assessed with ultrasound dilution technique.
The technical success rate was 100%, as were the anatomic and clinical success rates. Via Kaplan-Meier method, the primary access patency rates were 94.1% at 3 months (95% CI, 0.461-0.995) and 88.2% at 6 and 12 months (95% CI, 0.468-0.980). The primary lesion patency rate was 94.1% (95% CI, 0.650-0.992) at 3, 6, and 12 months. The secondary access patency rate had a point estimate of 100% at 3 months, and was 93.8% (95% CI, 0.632-0.991) at 6 and 12 months. Univariate analysis suggested that male sex and left-sided accesses were associated with a longer primary access patency rate (P = .02). The binary restenosis rate at 6 months was 5.9%. Mean transonic flow rates were 667.5 mL/min before intervention and 2,076.0 mL/min after intervention (P = .03, Wilcoxon signed-rank test). No patients were lost to follow-up.
Stent-graft placement in dysfunctional autogenous hemodialysis fistulas is technically feasible and effective in preserving function and preventing access abandonment, with patency rates that exceed historical patency rates with angioplasty and/or uncovered stents.
评估带膜支架置入术治疗自体动静脉内瘘功能不良的临床疗效。
2006 年 9 月至 2008 年 6 月,对 17 例自体动静脉内瘘功能不良患者(2 例头臂静脉型,12 例肱动脉-头静脉型,3 例肱动脉-贵要静脉型)行 24 例 Fluency Plus 带膜支架置入术。6 例内瘘在就诊时已发生血栓形成。带膜支架置入的适应证包括 10 例狭窄,6 例假性动脉瘤和 1 例吻合口瘘修补术后破裂。采用超声稀释法评估内瘘术前和术后的功能。
技术成功率为 100%,解剖成功率和临床成功率均为 100%。Kaplan-Meier 法计算的 3 个月时主要通路通畅率为 94.1%(95%可信区间,0.461-0.995),6 个月和 12 个月时分别为 88.2%(95%可信区间,0.468-0.980)。3 个月、6 个月和 12 个月时主要病变通畅率分别为 94.1%(95%可信区间,0.650-0.992)。3 个月时次要通路通畅率的点估计值为 100%,6 个月和 12 个月时分别为 93.8%(95%可信区间,0.632-0.991)。单因素分析提示男性和左侧通路与较长的主要通路通畅率相关(P =.02)。6 个月时的二元再狭窄率为 5.9%。内瘘术前平均跨声速血流速度为 667.5 mL/min,术后为 2076.0 mL/min(P =.03,Wilcoxon 符号秩检验)。无患者失访。
带膜支架置入术治疗自体动静脉内瘘功能不良是一种可行且有效的方法,可保留内瘘功能并预防通路废弃,通畅率高于血管成形术和/或裸支架的通畅率。